ANGION BIOMEDICA CORP (ANGN)
US03476J1079 - Common Stock
| TTM (2023-3-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -29.10M | -38.81M | -54.57M | -80.11M | -40.66M | |||
| Depreciation Amortization | 168.00K | 178.00K | 91.00K | 100.00K | 50.00K | |||
| Change In Working Capital | -7.19M | -4.23M | -25.97M | 25.77M | 9.75M | |||
| Interest Paid | N/A | 0.00 | 7.00K | N/A | 0.00 | |||
| Taxes Paid | N/A | N/A | N/A | N/A | 0.00 | |||
| Other non cash items | 5.31M | 4.47M | 27.81M | 31.35M | 6.27M | |||
| OPERATING CASH FLOW | -30.82M | -38.39M | -52.64M | -22.89M | -24.59M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | 0.00 | -382.00K | -40.00K | -240.00K | |||
| INVESTING CASH FLOW | -10.00M | 0.00 | -382.00K | -40.00K | -240.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -287.00K | -58.00K | 293.00K | 32.12M | 5.27M | |||
| Stock Issued/Repurchased | N/A | 0.00 | -617.00K | 20.81M | -380.00K | |||
| Other Financing Activity | -3.03M | -2.00K | 107.50M | -520.00K | N/A | |||
| FINANCING CASH FLOW | -3.31M | -60.00K | 107.17M | 52.41M | 4.89M | |||
| Exchange Rate Effect | 347.00K | 181.00K | 3.00K | -440.00K | N/A | |||
| CHANGE IN CASH | -43.78M | -38.27M | 54.15M | 29.04M | -19.94M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -30.82M | -38.39M | -52.64M | -22.89M | -24.59M | |||
| Capital Expenditure | N/A | 0.00 | -382.00K | -40.00K | -240.00K | |||
| FREE CASH FLOW | -30.82M | -38.39M | -53.02M | -22.93M | -24.83M | |||
All data in USD